| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/30/2009 | EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
| 12/30/2009 | EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis |
| 12/30/2009 | EP1470239B1 Psoriasin expression by breast epithelial cells |
| 12/30/2009 | EP1448567B1 Method for the preparation of hexahydro-furo 2,3-b furan-3-ol |
| 12/30/2009 | EP1448565B1 ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 12/30/2009 | EP1430019B1 Sphingolipids |
| 12/30/2009 | EP1309327B1 Pharmaceutical compositions of estrogenic agents |
| 12/30/2009 | EP1307108B1 Oil/fat composition |
| 12/30/2009 | EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/30/2009 | EP1242012B1 Improved transdermal contraceptive delivery system and process |
| 12/30/2009 | EP1202973B1 Preparation of compounds useful for the detection of hypoxia |
| 12/30/2009 | EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof |
| 12/30/2009 | CN201370888Y Multifunctional medicated pad |
| 12/30/2009 | CN101616678A Polyethylene glycol-G-CSF conjugate |
| 12/30/2009 | CN101616677A Lipid containing formulations |
| 12/30/2009 | CN101616676A Use of tri-substituted glycerol compounds for the treatment of hematological malignancies |
| 12/30/2009 | CN101616675A Combination of a glucocorticoid and a ss-cyclodextrin conjugated vitamin a derivate complex |
| 12/30/2009 | CN101616674A Maleic acid monosalt of antiviral agent and pharmaceutical composition containing the same |
| 12/30/2009 | CN101616673A Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile |
| 12/30/2009 | CN101616672A Imidazoquinolines as dual lipid kinase and mTOR inhibitors |
| 12/30/2009 | CN101616671A Composition for treatment of pancreatic cancer |
| 12/30/2009 | CN101616670A Novel methods |
| 12/30/2009 | CN101616669A Methods for the treatment of alcohol abuse, addiction and dependency |
| 12/30/2009 | CN101616667A Heterocyclic amide compounds useful as kinase inhibitors |
| 12/30/2009 | CN101616666A Pharmaceutical composition for treatment and prevention of restenosis |
| 12/30/2009 | CN101616665A Composition useful for the treatment of type 2 diabetes |
| 12/30/2009 | CN101616664A Use of gabapentin and pregabalin prodrugs for treating tinnitus |
| 12/30/2009 | CN101616663A Method for alleviating keratoconjunctivitis sicca |
| 12/30/2009 | CN101616662A Pharmaceutical composition for treatment of diabetic complications |
| 12/30/2009 | CN101616661A Compounds and uses thereof |
| 12/30/2009 | CN101613688A Von willebrand factor (vWF)-cleaving protease |
| 12/30/2009 | CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/30/2009 | CN101613310A Method of preparing amine stereoisomers |
| 12/30/2009 | CN101613307A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 12/30/2009 | CN101612160A Application of 20(S)-ginsenoside Rh2 compound in preparing antidepressant medicament |
| 12/30/2009 | CN101612159A Application of 20(S)-ginsenoside Rh2 compound in preparing anti-fatigue medicament |
| 12/30/2009 | CN101612158A Compound ofloxacin injection for animals for treating postnatal infection and preparation method thereof |
| 12/30/2009 | CN101612157A Application of fasudil on leading adult brain endogenous neural stem cells to be regenerated |
| 12/30/2009 | CN101612156A Medicinal composition for lowering blood pressure |
| 12/30/2009 | CN101612155A Method for removing gram negative bacilli by using piperacillin and tazobactam compound preparation |
| 12/30/2009 | CN101612154A Pivampicillin-containing composition, preparation method thereof and use thereof |
| 12/30/2009 | CN101612153A Broad-spectrum pivampicillin-containing antimicrobial pharmaceutical composition and preparation method |
| 12/30/2009 | CN101612152A Pidotimod-containing pharmaceutical composition and preparation method thereof |
| 12/30/2009 | CN101612151A Solid oral administration preparation containing Candesartan cilexetil or Candesartan Hydrochlorothiazide and method for preparing solid oral administration preparation |
| 12/30/2009 | CN101612150A Isoconeazole nitrate vagina soft capsule and preparation method thereof |
| 12/30/2009 | CN101612149A New applications of hematoporphyrin monomethyl ether in the field of medicine |
| 12/30/2009 | CN101612148A Daily use chemical product for treating dermatophytosis and producing method thereof |
| 12/30/2009 | CN101612147A Application of alpha-mangostin in preparing inflammation-resisting pain-relieving medicine |
| 12/30/2009 | CN101612146A Oxaliplatin medicament composition, preparation method thereof and method for synthesizing oxaliplatin as raw medicinal material |
| 12/30/2009 | CN101612145A Ferulic acid calcium injection and preparation method thereof |
| 12/30/2009 | CN101612144A Sustained-release preparation containing paracetamol and tramadol |
| 12/30/2009 | CN101612143A Application of Beta-aminoketones compound in preparing drug for inhibiting isocitrate lyase |
| 12/30/2009 | CN101612142A Application of phaseomannite derivant or salt thereof in medicine preparation |
| 12/30/2009 | CN100575497C Preparation of microbial oil containing polyunsaturated fatty acids |
| 12/30/2009 | CN100575365C Loose knot total polysaccharide and preparation method and usage thereof |
| 12/30/2009 | CN100575358C Honeysuckle extract and its preparation method and application |
| 12/30/2009 | CN100575352C 1-(4- chloroanilino)-4-(4-methylpyridyl)-2,3-diazophenodiazine synthesis and uses |
| 12/30/2009 | CN100575350C Macrocyclic glyceride with oxidization resistant activity and its preparation method and use |
| 12/30/2009 | CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes |
| 12/30/2009 | CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 12/30/2009 | CN100575341C Tetrahydro-indolone derivative and tetrahydro-indazolone derivatives and their use |
| 12/30/2009 | CN100575335C Amino-propanol derivatives |
| 12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/30/2009 | CN100574813C A lock solution for medical devices and its uses |
| 12/30/2009 | CN100574806C Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
| 12/30/2009 | CN100574805C Therapeutic infusion containing fructose |
| 12/30/2009 | CN100574797C Plaster for treating osteopathy |
| 12/30/2009 | CN100574782C Application of aqueous solution containing nicotine in preparing medicine for quit smoking |
| 12/30/2009 | CN100574780C Compositions against inflammatory processes |
| 12/30/2009 | CN100574779C Compound oil for treating empyrosis and skin infection and method for preparation thereof |
| 12/30/2009 | CN100574773C Oral medicine of combined traditional Chinese and Western medicine for treating bacteria finrot disease of grass carp |
| 12/30/2009 | CN100574772C Soft capsule containing lutein and its preparation method |
| 12/30/2009 | CN100574768C An anticancer medicinal composition, preparing method and use thereof |
| 12/30/2009 | CN100574767C Composition for preventing mammmal vagina infection and use |
| 12/30/2009 | CN100574765C A medicine for treating hyperphosphatemia disease and iron deficiency anemia disease |
| 12/30/2009 | CN100574764C Anti-hepatitis pharmaceutical composition and preparation process thereof |
| 12/30/2009 | CN100574763C Topically stabilized prostaglandin E compound dosage forms |
| 12/30/2009 | CN100574762C Portulaca total flavone injection and method for making same |
| 12/30/2009 | CN100574761C Mycophenolate mofetil dry suspension agent |
| 12/30/2009 | CN100574760C Camptothecinum-layered thermometal hydroxide nanometer complexes preparation method |
| 12/30/2009 | CN100574759C Method for preparing lansoprazole intestine dissolving capsule |
| 12/30/2009 | CN100574758C Compound for treating ischemic related disease |
| 12/30/2009 | CN100574757C Acetylcysteine or its salt and anti-infectious medicine composition |
| 12/30/2009 | CN100574756C Oral preparation having improved bioavailability |
| 12/30/2009 | CN100574755C Hot melt transcutaneous therapeutic system for administering D2 accelerator |
| 12/30/2009 | CN100574754C Preparation method of total coumarins extract from peucedanum praeruptorum dunn |
| 12/30/2009 | CN100574753C Medicinal salt with local narcosis and antiphlogosis activity and its preparation process |
| 12/30/2009 | CN100574752C Medicine composition for preventing and curing schemic cerebrovaseular disease as well as preparation method thereof |
| 12/30/2009 | CN100574751C Tiotropium containing powder formulation for inhalation |
| 12/30/2009 | CN100574750C Rapidly-disintegrating formulation for releasing active ingredients |
| 12/30/2009 | CN100574747C Pediatric paracetamol gelatin preparation for children and its preparing method |
| 12/30/2009 | CN100574742C Topical composition containing hyaluronic acid fragments and retinoid useful for cosmetic and medical dermatology |
| 12/30/2009 | CN100574638C Compound containing DAG and the method for preparing the same |
| 12/30/2009 | CA2847644A1 Glycerophospholipids for the improvement of cognitive functions |
| 12/30/2009 | CA2766328A1 New therapeutic agents |
| 12/30/2009 | CA2766282A1 Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue |
| 12/30/2009 | CA2763536A1 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria |
| 12/30/2009 | CA2729604A1 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
| 12/30/2009 | CA2729546A1 Compounds and compositions as kinase inhibitors |